Your browser doesn't support javascript.
loading
Selective HDAC inhibition for the disruption of latent HIV-1 infection.
Barton, Kirston M; Archin, Nancie M; Keedy, Kara S; Espeseth, Amy S; Zhang, Yan-ling; Gale, Jennifer; Wagner, Florence F; Holson, Edward B; Margolis, David M.
Afiliación
  • Barton KM; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Archin NM; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Keedy KS; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Espeseth AS; Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America.
  • Zhang YL; Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, United States of America.
  • Gale J; Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, United States of America.
  • Wagner FF; Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, United States of America.
  • Holson EB; Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, United States of America.
  • Margolis DM; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; Department of Epidemiology, Unive
PLoS One ; 9(8): e102684, 2014.
Article en En | MEDLINE | ID: mdl-25136952

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / VIH-1 / Fármacos Anti-VIH / Histona Desacetilasa 1 / Histona Desacetilasa 2 / Inhibidores de Histona Desacetilasas / Histona Desacetilasas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / VIH-1 / Fármacos Anti-VIH / Histona Desacetilasa 1 / Histona Desacetilasa 2 / Inhibidores de Histona Desacetilasas / Histona Desacetilasas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos